Riskpilot← Back to searchSign inGet full accessMASTER SURGERY SYSTEMS AS
ASActiveOrg 993550116Sollistrandsveien 12, 3187 HortenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20091 employees
Revenue 2025
NOK 3,8M
+13% vs 2024
EBITDA margin
2.2%
+251% vs 2024
Equity ratio
67.0%
Financial strength
Net profit 2025
NOK -37K
+43% vs 2024
| Revenue | NOK 3,8M | +13% |
| EBITDA | NOK 85K | +251% |
| Net profit | NOK -37K | +43% |
| Total assets | NOK 2M | +10% |
| Equity | NOK 1,4M | -3% |
| Employees | 1 | — |
Legal name
MASTER SURGERY SYSTEMS AS
Org number
993550116
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. januar 2009
Share capital
NOK 400 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikling, produksjon og distribusjon av medisinsk teknisk utstyr, salg av relaterte konsulenttjenesterinnenfor områdene produktutvikling, salg og forretningsutvikling samt alt som hører naturlig inn under dette, herunder deltakelse i andre virksomheter.
Address
Sollistrandsveien 12, 3187 Horten
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 876 | 1 671 | 3 210 | 5 006 | 8 184 | 5 985 | 9 223 | 6 264 | 5 503 | 5 242 | 3 580 | 3 232 | 3 018 | 2 325 | 3 511 | 3 335 | 3 777 |
| Staff expenses | −279 | −3 | −387 | −854 | −826 | −474 | −659 | −1 068 | −1 260 | −749 | −1 001 | −684 | −1 114 | −560 | −758 | −885 | −1 080 |
| EBITDA | −144 | 307 | 635 | 208 | −94 | 669 | 944 | 197 | −379 | 322 | 32 | −87 | −11 | 95 | 212 | −56 | 85 |
| Depreciation & amort. | −27 | −54 | −117 | −149 | −46 | −52 | −63 | −29 | −17 | −17 | −17 | −3 | −1 | −5 | −5 | −5 | −5 |
| EBIT | −171 | 253 | 518 | 59 | −140 | 617 | 880 | 168 | −396 | 305 | 15 | −90 | −13 | 90 | 207 | −61 | 80 |
| Net financials | 0 | −36 | −27 | −20 | 5 | −124 | −193 | −71 | −92 | −59 | −63 | −39 | −33 | −31 | −18 | −21 | −99 |
| Profit before tax | −170 | 217 | 490 | 39 | −135 | 493 | 688 | 96 | −487 | 245 | −48 | −128 | −46 | 59 | 189 | −82 | −19 |
| Tax | −0 | 14 | 139 | 12 | 13 | 99 | 210 | 15 | −0 | −0 | −0 | −0 | −0 | −0 | −64 | −17 | 18 |
| Net profit | −170 | 203 | 351 | 26 | −148 | 394 | 478 | 81 | −487 | 245 | −48 | −128 | −46 | 59 | 253 | −65 | −37 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 579 | 1 071 | 1 520 | 2 813 | 3 676 | 3 262 | 3 751 | 3 821 | 2 932 | 2 665 | 2 166 | 1 578 | 1 584 | 1 728 | 1 818 | 1 866 | 2 048 |
| Equity | 41 | 243 | 794 | 821 | 672 | 1 066 | 1 544 | 1 626 | 1 139 | 1 384 | 1 336 | 1 208 | 1 162 | 1 221 | 1 474 | 1 409 | 1 372 |
| Long-term debt | 0 | 0 | 0 | 530 | 353 | 379 | 479 | 354 | 574 | 383 | 192 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 328 | 511 | 723 | 1 462 | 2 651 | 1 817 | 1 728 | 1 841 | 1 219 | 898 | 638 | 370 | 422 | 507 | 344 | 457 | 676 |
| Total debt | 538 | 827 | 726 | 1 992 | 3 004 | 2 196 | 2 207 | 2 195 | 1 793 | 1 281 | 830 | 370 | 422 | 507 | 344 | 457 | 676 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20092025
Equity ratio
67.0%
This company
38.2%
Market median
+75% vs market
20092025
Return on equity
-2.7%
This company
18.4%
Market median
-115% vs market
20092025
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20092025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20092025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20092025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Board of Directors | 2016 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MASTER SURGERY SYSTEMS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Nilsen | Chairman | 0 companies |
| Liv Nilsen | Board of Directors | 0 companies |